Home
>
National Drug Code (NDC)
>
Carisoprodol
Carisoprodol - 51525-5901-1 - (carisoprodol)
Drug Information of Carisoprodol
| Product NDC: | 51525-5901 |
| Proprietary Name: | Carisoprodol |
| Non Proprietary Name: | carisoprodol |
| Active Ingredient(s): | 250 mg/1 & nbsp; carisoprodol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carisoprodol
| Product NDC: | 51525-5901 |
| Labeler Name: | Wallace Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011792 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20100701 |
Package Information of Carisoprodol
| Package NDC: | 51525-5901-1 |
| Package Description: | 100 TABLET in 1 BOTTLE (51525-5901-1) |
NDC Information of Carisoprodol
| NDC Code | 51525-5901-1 |
| Proprietary Name | Carisoprodol |
| Package Description | 100 TABLET in 1 BOTTLE (51525-5901-1) |
| Product NDC | 51525-5901 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | carisoprodol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100701 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Wallace Pharmaceuticals Inc. |
| Substance Name | CARISOPRODOL |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
